Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selexipag in Schistosomiasis-Associated PAH
NCT04589390Phase 2Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Oct 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selexipag in pulmonary arterial hypertension (PAH), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Status: unknown.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT04589390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589390.